Al Rashdi Fakhria, Al Harrasi Salwa, Al Ismaili Mohammed, Yaaqubi Al-Ghaliya Al, Atwan Zeenah, Tabche Celine
Ministry of Health Sultan Oman, Muscat, Sultanate, Oman.
School of Public Health / WHO Collaborating Centre/Department of Primary Care and Public Health/Imperial College London, Baghdad, Iraq.
BMC Prim Care. 2024 Dec 21;25(1):432. doi: 10.1186/s12875-024-02672-2.
The COVID-19 pandemic has led to a significant shift in healthcare services, focusing on pandemic response and emergency preparedness. The Oman Ministry of Health implemented various measures to combat and control COVID-19. However, this shift disrupted routine outpatient appointments, particularly for chronic diseases such as diabetes mellitus (DM) and hypertension (HTN). This study aims to assess the pandemic's effect on diabetes control, by examining glycated haemoglobin (HbA1c), blood pressure (BP), lipid values (particularly low-density lipoprotein (LDL), body weight/ body mass index (BMI), and comparing these measures to pre-pandemic levels.
A retrospective cohort study of 223 people with diabetes (PwD), aged 20-95 years who underwent a blood workup in 2019 and 2020 and were registered in Al-Khuwair Health Centre from March to December 2020. Data was extracted from the Al Shifa 3plus System and National Diabetic Register (NDR), and analyzed using SPSS.
Out of 260 PwD identified, 223 met the inclusion criteria, while 37 were excluded due to recent diagnoses or missing follow-up in 2019. Significant changes were observed in HbA1C, systolic blood pressure (SBP), and BMI from 2019 to 2020. Mean HbA1c increased from 6.9% in 2019 to 7.2% in 2020. Mean SBP rose from 131.22 mmHg in 2019 to 134.84 mmHg in 2020, while mean BMI increased from 30.49 to 30.80. No significant changes were found in LDL levels or diastolic BP.
The COVID-19 pandemic disrupted healthcare systems globally, and the consequences on health and mortality were not only due to the direct impact of the virus, but also to the modifications in priorities. These interruptions in inconsistent care, had consequences for non-communicable diseases (NCDs) like diabetes. Future strategic plans should be prepared and implemented to manage NCD cases in case of pandemics.
新冠疫情导致医疗服务发生重大转变，重点转向疫情应对和应急准备。阿曼卫生部实施了各种措施来抗击和控制新冠疫情。然而，这种转变扰乱了常规门诊预约，尤其是糖尿病（DM）和高血压（HTN）等慢性病的预约。本研究旨在通过检测糖化血红蛋白（HbA1c）、血压（BP）、血脂值（特别是低密度脂蛋白（LDL））、体重/体重指数（BMI），并将这些指标与疫情前水平进行比较，评估疫情对糖尿病控制的影响。
一项回顾性队列研究，研究对象为223名年龄在20 - 95岁之间的糖尿病患者（PwD），他们于2019年和2020年接受了血液检查，并于2020年3月至12月在Al-Khuwair健康中心登记。数据从Al Shifa 3plus系统和国家糖尿病登记处（NDR）提取，并使用SPSS进行分析。
在确定的260名PwD中，223名符合纳入标准，37名因2019年近期诊断或失访而被排除。从2019年到2020年，HbA1C、收缩压（SBP）和BMI出现了显著变化。平均HbA1c从2019年的6.9%升至2020年的7.2%。平均SBP从2019年的131.22mmHg升至2020年的134.84mmHg，而平均BMI从30.49增至30.80。LDL水平或舒张压未发现显著变化。
新冠疫情扰乱了全球医疗系统，对健康和死亡率的影响不仅源于病毒的直接影响，还源于优先事项的改变。这些护理的中断对糖尿病等非传染性疾病（NCD）产生了影响。应制定并实施未来战略计划，以便在疫情期间管理非传染性疾病病例。
